Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice
暂无分享,去创建一个
M. Lukáš | K. Malíčková | R. Vaníčková | V. Hrubá | M. Lukas | M. Bortlík | K. Mitrová | D. Ďuricová | N. Machková | M. Vašátko | K. Pudilova | M. Kolář